Navco Pharmaceuticals (TSXV:NAV) Other Operating Expense : C$0.02 Mil (TTM As of Mar. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Navco Pharmaceuticals Other Operating Expense?

Navco Pharmaceuticals's Other Operating Expense for the three months ended in Mar. 2023 was C$0.01 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2023 was C$0.02 Mil.

Navco Pharmaceuticals's quarterly Other Operating Expense increased from Sep. 2022 (C$0.00 Mil) to Dec. 2022 (C$0.00 Mil) and increased from Dec. 2022 (C$0.00 Mil) to Mar. 2023 (C$0.01 Mil).

Navco Pharmaceuticals's annual Other Operating Expense declined from Jun. 2019 (C$0.04 Mil) to Jun. 2020 (C$0.02 Mil) and declined from Jun. 2020 (C$0.02 Mil) to Jun. 2021 (C$0.02 Mil).

Navco Pharmaceuticals Other Operating Expense Historical Data

The historical data trend for Navco Pharmaceuticals's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Navco Pharmaceuticals Other Operating Expense Chart

Navco Pharmaceuticals Annual Data

Trend

Jun18

Jun19

Jun20

Jun21

Other Operating Expense

0.04

0.02

Navco Pharmaceuticals Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Other Operating Expense	Get a 7-Day Free Trial														0.01	-	-	-	0.01

Navco Pharmaceuticals Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.02 Mil.

Navco Pharmaceuticals Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Navco Pharmaceuticals's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Navco Pharmaceuticals (TSXV:NAV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Navco Pharmaceuticals Inc (TSXV:NAV) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

1055 West Georgia Street, Suite 1500, Vancouver, BC, CAN, V6E 4N7

Website

Navco Pharmaceuticals Inc uses of nanotechnology to develop and commercialize novel products to protect against viruses, bacteria, and infectious diseases. The company's pipeline of applications is tailored to defend against pathogens utilizing new methods of action to capitalize on unmet product needs using natural & known compounds, nanoparticles, and no chemicals with a high degree of efficacy. Its target markets include human health & personal skin care, household & institutional products, and veterinary health.